European Companies Search Engine

Quick Search Power Search
Tips & Tricks
Our help pages Using the Quick Search and Power Search Overview explain how to use our search engine.

11 EU fundings (total €39.2M): Iact … BdlYear 2013 Financial Transparency System

Text

Deutsches Krebsforschungszentrum Stiftung des öffentlichen Rechts, Heidelberg, Germany

01/06/2013 EU funding (€100,000): Support of a European Research Career: Analysis of Tenascin C Function in Breast Cancer Metastasis to Bone
01/09/2013 EU funding (€100,000): Support of a European Research Career: T-Cell Based Immunotherapy in Pancreatic Cancer - Basic Concepts and PRE-Clinical Development
01/05/2013 EU funding (€2,296,300): Supersist
01/05/2013 EU funding (€3,599,998): Supersist
01/05/2013 EU funding (€3,620,422): Quantitative T Cell Immunology
01/01/2013 EU funding (€5,352,972): Phase I/II Gene Therapy Trial of Fanconi Anemia Patients with a New Orphan Drug Consisting of a Lentiviral Vector Carrying the Fanca Gene: a Coordinated International Action
01/01/2013 EU funding (€5,501,063): *****
01/10/2013 EU funding (€5,931,505): Requite
01/11/2013 EU funding (€5,975,763): Iact
01/02/2013 EU funding (€5,999,231): Pathway-27
01/05/2013 EU funding (€749,745): Deciphering the Regulatory T Cell Repertoire: Towards Biomarkers and Biotherapies for Autoimmune Diseases

This filing was translated from to English. The filing refers to a past date, and does not necessarily reflect the current state. The current state is available on the following page: Deutsches Krebsforschungszentrum Stiftung des öffentlichen Rechts, Heidelberg, Germany.

Creative Commons License The visualizations for "Deutsches Krebsforschungszentrum Stiftung des öffentlichen Rechts - 11 EU fundings (total €39.2M): Iact …" are provided by North Data and may be reused under the terms of the Creative Commons CC-BY license.

Printing is only available to North Data premium service subscribers.
Close